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The most important goal of fertility investigation is to
identify the cause(s) of infertility and to prescribe ad-
equate therapy. The couple should be treated as a
single unit as each partner contributes a share to the
infertility potential of the couple. Evaluation should
begin with the taking of a detailed history and a com-
plete physical examination of both partners, which
may point the investigation in a particular direction.
However, other pertinent fertility factors should not
be overlooked. A standardized and comprehensive ap-
proach to the investigation of infertility is proposed
and is presented as a series of flow charts.
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diagnosis/male infertility/reproduction techniques
Introduction
The standard medical definition of infertility is the inability
of a couple to conceive after 12 months of intercourse
without the use of contraception (U.S. Congress, Office of
Technology Assessment, 1988). The most important goal
of the fertility investigation is to identify the cause(s) of
infertility and to prescribe adequate therapy. This is not the
only task of the physician, however, as s/he should also
provide the couples with accurate information and often
will need to correct misinformation gained from friends or
family. The physician also has to provide emotional sup-
port for the couple during the period of investigation and
treatment.
The work reported here proposes a standardized and
comprehensive approach to infertility investigation. For
this reason, we have adopted the idea of presenting the
subject in the form of serial flow charts in well-organized
steps.
The Infertile couple
The couple must be considered as a single unit, as each
partner contributes a share to the infertility potential of the
couple. The approach to infertility requires an efficient and
complete initial evaluation. Many couples have more than
one contributory cause which should be identified early in
the evaluation. The main framework for evaluation of the
couple is summarized in Figure 1. Evaluation must begin
with the recording of a detailed history and a complete
physical examination of both partners. Couples must be
asked about all items related to infertility when compiling
their histories. A prc-morbid history should be analysed in
detail concerning the disease, the investigations done, and
the treatment. The history and/or physical examination
may direct the evaluation in a particular direction, but other
pertinent fertility factors should not be overlooked.
Diagnosis of female infertility
History-taking and physical examination
Factors that should be recorded in the history of the female
partner are described in Figures 2 and 3 (Campana and
Lemiere-De Vita, 1985; Rowe and Farley, 1988; Speroff et
aL, 1989;Sciarra, 1992; Yen and Jaffe, 1991). The items of
the history in the flow charts are organized so as to cover
the most common, and the most important causes of female
partner infertility. The physician should investigate all the
items in order to obtain a valuable impression about the
possible cause(s) of the infertility. Any positive history
should be analysed in detail. The general condition of the
female partner should be assessed by a thorough general
physical examination. Pelvic examination is of course the
cornerstone in infertility evaluation. Any suspected lesion
'To whom correspondence should be addressed. Tel: (41) 22 382 4336; Fax: (41) 22 382 4310
Evaluation of infertility 587
FLOW CHART 1. EVALUATION OF THE INFERTILE COUPLE
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Figure 1. Evaluation of the infertile couple. FC = flow chart; BBT =
basal body temperature; HSG = hysterosalpingography; CM = cervi-
cal mucus; PCT = postcoital test
should be investigated thoroughly, while always keeping in
mind its relation to the infertility problem (Figure 4).
After completion of the initial steps of evaluation (history-
taking and physical examination), a plan should be adopted
by the physician to assess the factors which are necessary to
achieve a successful pregnancy. This is accomplished by the
assessment of menstrual and ovulatory status and tuboperito-
neal, uterine and cervical factors (Figure 5).
Assessment of menstrual and ovulatory status
The different types of menstrual behaviour are described in
Figure 6. In the presence of regular spontaneous cycles, the
questions to be answered, using basal body temperature
(BBT) measurement, endovaginal ultrasound and mid-lu-
teal serum progesterone evaluations, are whether the pa-
tient is ovulating or not, in the presence of ovulation did
follicular rupture occur, did it occur at the proper time, and
was the luteal phase adequate? Moreover, the status of the
endometrium should also be evaluated (Figure 7) (Rowe
and Farley, 1988; Speroff et al., 1989; Sciarra, 1992). Oli-
gomenorrhoea, which is cyclic menstrual bleeding occur-
ring at intervals of >35 days but <6 months, is managed
according to the length of the cycle (Figure 6).
Patients presenting with primary amenorrhoea are
subdivided according to the appearance of the external
genitalia into patients with ambiguous external genitalia
and those with normal female external genitalia. The latter
group of patients is further subdivided into four subgroups
according to the presence (+) or absence (-) of the uterus as
well as breast development (Figure 8) (Mishell et al,
1991).
General dm
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Figure 2. History of the female partner. FC = flow chart; DES = diethylstilbcstrol; PID = pelvic inflammatory disease; STD = sexually trans-
mitted disease.
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Figure 3. History of the female partner—iatrogenic factors.
FLOW CHART 4. PHYSICAL EXAMINATION OF THE FEMALE PARTNER
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Figure 4. Physical examination of the female partner.
Patients with primary amenorrhoea, intact uterus and an
absence of breast development should be subjected to
serum follicle stimulating hormone (FSH) measurement
Accordingly, the patients are classified into either hypogo-
nadotrophic hypogonadism or hypergonadotrophic hypo-
gonadism. In the latter group of patients karyotyping is
indicated. If blood pressure is elevated, the likely diagnosis
is 17A-hydroxylase deficiency with 46,XX karyotype. If
blood pressure is normal, the results of karyotyping will be
either 46.XX indicating pure gonadal dysgenesis (or
ovarian lesions), 46.XY indicating pure gonadal dysgenesis,
or the karyotype will be abnormal. Where the karyotype is
abnormal, one should look for signs of hirsutism. If hirsut-
ism is present, mixed gonadal dysgenesis is expected
FLOW CHART 5. DIAGNOSIS OF FEMALE INFERTILITY CAUSES
• FC2-Hhoc<7
FC4-Pbrsicil
PC6-Measmal md
ixcnDO tictor
f^  V^-Altf IHTlf IT of
Figure 5. Diagnosis of female infertility causes. FC = flow chart
However, if hirsutism is not present, the diagnosis could be
45.X Turner's syndrome, mosaicism or 46,XX with an
abnormal X chromosome (Figure 9) (Mishell etaL, 1991)-
Patients with primary amenorrhoea, absent uterus and
developed breasts should also be subjected to karyotyping.
Congenital absence of the uterus is diagnosed when the
karyotype is 46,XX, while androgen insensitivity is the
diagnosis when the karyotype is 46,XY (Figure 10) (Mis-
hell et al, 1991). Patients with primary amenorrhoea, ab-
sent uterus and absent breast development all belong to the
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Figure 6. Menstrual and ovulatory status. FC = flow chart.
FLOW CHART 7. REGULAR MENSES |
Figure 7. Regular menses. FC = flow chart.
category of male pseudohermaphroditism with 46,XY ka-
ryotype (Figure 10).
In patients with primary amenorrhoea, intact uterus and
well-developed breasts, one should inquire about the pres-
ence of cyclic pelvic pain. Abnormalities of the Miillerian
ducts and related embryonic structures should be suspected
in the presence of this type of pain. In the absence of cyclic
pain, the patients should be classified as having hypergona-
dotrophic or normo-hypogonadotrophic hypogonadism
according to serum FSH concentrations. Accordingly, the
patients are investigated as in Figure 11 (Mishell et al.,
1991; Speroff era/., 1989).
Patients with primary amenorrhoea and ambiguous ex-
ternal genitalia should be karyotyped. A 46.XX karyotype
combined with elevated androgens and 17-hydroxyproges-
terone (17-OHP) indicates the presence of congenital ad-
renal hyperplasia. If the androgens and 17-OHP
concentrations are normal, the diagnosis is either elevated
androgen in the maternal blood or 46,XX true hermaphro-
ditism. Patients with a Y-containing abnormal karyotype
may represent XX/XY true hermaphroditism or mixed go-
nadal dysgenesis. Patients with an XY karyotype are
classified into three classes according to the presence or
absence of the gonads. If the gonads are present on both
sides and the uterus is present, the diagnosis is true her-
maphroditism. If the uterus is absent and there is a rudi-
mentary Wolffian duct, incomplete androgen insensitivity
is the likely diagnosis. If the uterus is absent and the Wolf-
fian duct is present, but lacking the prostate, the diagnosis
is 5A-reductase deficiency. If the uterus is absent and the
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Figure 9. Amenorrhoca - breast development (-)/uterus (+). FSH = follicle stimulating hormone; GnRH = gonadotrophin-releasing hormone.
Wolffian duct is completely present, abnormal androgen
synthesis is the diagnosis. If the gonads are present on one
side only, the diagnosis is mixed gonadal dysgenesis. The
third class represents those with gonadal streaks on both
sides. If the uterus is absent, this represents testicular re-
gression syndrome, while if the uterus is present, the diag-
nosis is late onset agonadism. If both Mullerian and
Wolffian ducts are present in a rudimentary form, the diag-
nosis is testicular dysgenesis (Figure 12) (Speroff et al,
1989; Mishell et al., 1991; Yen and Jaffe, 1991).
In patients with secondary amenorrhoea, one should
start by excluding a history of hypophysectomy, bilateral
oophorectomy, hysterectomy, castration by irradiation and
chemotherapy. This should be followed by exclusion of
pregnancy, then the patients are classified into amenor-
rhoea with suggestive history, amenorrhoea with sugges-
tive symptoms and signs, and non-suggestive amenorrhoea
(Figure 13) (Mishell etal., 1991; Speroff et al., 1989).
Amenorrhoea accompanied by galactorrhoea should be
first investigated by measuring prolactin serum concentra-
tions (Figure 13) followed by the investigations shown in
Figure 11.
In cases of secondary amenorrhoea with recurring cyclic
pain and a history of cervical surgery and/or the presence
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Figure 10. Primary amenorrhoea - absence of uterus. LH = luteinizing hormone; 3f5-HSD = 3f}-hydroxysteroid dehydrogenase.
FLOW CHART H . AMENORRHOEA-BREAST DEVELOPMENT (•) / UTERUS (<•)
Figure 11. Amenorrhoea - breast development (+)/uterus (+). FSH = follicle stimulating hormone; TSH = thyroid-stimulating hormone; CAT =
computerized axial tomography; MRI magnetic resonance imaging.
of a cervical mass by pelvic examination, endovaginal
ultrasonography should be done. The presence of haema-
tometra will confirm the diagnosis of obstructive amenorr-
hoea (Figure 13).
History of drug intake with known impact on ovulation
and/or the endometrium may be the cause of amenorrhoea.
The suspicion of Asherman's syndrome is aroused by amen-
orrhoea following curettage or endometritis. Amenorrhoea
following severe postpartum haemorrhage and failure of
lactation is suggestive of Sheehan's syndrome. If amenor-
rhoea follows tuberculosis, schistosomiasis or endometrial
irradiation one should suspect endometrial destruction. One
should not forget psychogenic factors, nutritional factors and
exercise, which are frequent causes of secondary amenor-
rhoea (Figure 14) (Speroff et aL, 1989; Mishell etaL, 1991;
Yen and Jaffe, 1991; Sciarra, 1992).
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Figure 12. Primary amenorrhoca - ambiguous external genitalia. 17-OHP = 17-hydroxyprogesterone; T = testosterone; DHT = dihydrotestos-
terone; A-4 = androstencdione.
FLOWCHART 13. SECONDARY AMENORRHOEA/ANOVULATORY CYCLES
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Figure 13. Secondary amenorrhoea/anovulatory cycles. FC = flow chart; BBT = basal body temperature.
In secondary amenorrhoea accompanied by hot flushes,
karyotyping is essential. An abnormal karyotype may
represent Turner's syndrome, mosaic Turner's syndrome
with XO/XX, or 46.XX with structural abnormality of the
X chromosome. If the patient is 46,XX a complete set of
investigations to exclude the presence of an autoimmune
process is essential. Serum luteinizing hormone (LH), FSH
and oestradiol concentrations should be measured together
with endovaginal ultrasound to differentiate between idio-
pathic premature menopause and resistant ovary syndrome
(Figure 15) (Speroff etal., 1989; Mishell etai, 1991; Yen
and Jaffe, 1991; Sciarra, 1992).
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FLOW CHART 14. SECONDARY AMENORRHOEA WITH SUGGESTIVE HISTORY
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Figure 14. Secondary amenorrhorea with suggestive history.
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Figure 15. Secondary amenorrhoea/anovulatory cycles-hot flushes. TSH = thyroid-stimulating hormone; FSH = follicle stimulating hormone;
LH = luteinizing hormone; E2 = oestradiol.
Cases of secondary amenorrhoea accompanied by hir-
sutism are investigated by first excluding the intake of
drugs of known androgenic effect. If Cushing's syndrome
is suspected from the symptoms or the signs, it should be
diagnosed or excluded according to the plan described in
Figure 16. However, if Cushing's syndrome is excluded or
is not suspected, serum testosterone and dehydroepian-
drosterone sulphate (DHEA-S) concentrations should be
measured (Wilson and Foster, 1992).
When testosterone concentrations are <2 ng/ml, poly-
cystic ovary syndrome should be suspected and should be
confirmed by endovaginal ultrasound and its peculiar hor-
monal profile. If testosterone concentrations are >2 ng/ml,
endovaginal ultrasound is indicated to diagnose or exclude
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Figure 16. Secondary amcnorrhoea/anovulatory cycles-hirsuiism. DHEA-S = dehydrocpiandrosterone sulphate; 17-OHCS = 17-hydroxycorti-
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hormone.
the presence of ovarian tumours. When ultrasonography
fails to reveal any ovarian mass, a computerized axial to-
mography (CAT) scan of the adrenals and ovarian venous
catheterization are indicated.
Serum concentrations of DHEA-S of <7 (ig/ml require
measurements of serum 17-OHP concentrations. If
17-OHP concentrations are <3 ng/ml, this rules out any
adrenal problem, whereas concentrations >8 ng/ml point to
late onset adrenal hyperplasia. Serum concentrations of
17-OHP between 3 and 8 ng/ml require the performance of
an adrenocorticotrophic hormone (ACTH) stimulation test
to rule out or diagnose adrenal hyperplasia. If DHEA-S
concentrations are >7 |J.g/ml, a dexamethasone suppression
test (2 mg q.i.d. for 5 days) is recommended. At the end of
the test, DHEA-S should be measured again. If suppression
was achieved, adrenal hyperplasia is suspected and should
be investigated by 17-OHP measurement. If suppression
was not the result, adrenal tumours should be suspected and
a CAT scan of the adrenals is recommended (Figure 17)
(Wilson and Foster, 1992).
Cases of secondary amenorrhoea with no suggestive his-
tory, signs or symptoms are investigated as indicated in
Figure 11. Patients with abnormal uterine bleeding are
candidates for BBT measurement and endovaginal ultra-
sonography to exclude or diagnose the presence of organic
lesions. In the absence of organic lesions, the diagnosis is
dysfunctional uterine bleeding of either ovulatory or non-
ovulatory nature as determined by BBT charts and the
cyclical occurrence of abnormal bleeding (Figure 18)
(Speroff etal, 1989; Sciarra, 1992).
Assessment of tuboperftoneal factor
Assessment of the tuboperitoneal factor requires investiga-
tion of the patients by hysterosalpingography, which gives
information about tubal patency, tubal dilatation, presence
of diverticulosis, and configuration of the mucosal folds,
but it cannot give a precise diagnosis of the presence or
absence of adnexal adhesions and peritoneal endometriotic
lesions. The latter lesions can be easily diagnosed by lap-
aroscopy, which is performed at the end of the infertility
work-up, or immediately after hysterosalpingography in
cases of abnormal tubal findings (Figure 19) (Rowe and
Farley, 1988; Mishell et aL, 1991; Sciarra, 1992).
Assessment of uterine factor
Assessment of the uterine factor is done routinely by the
use of the hysterogram and endovaginal ultrasonography.
When congenital uterine anomalies or uterine fibroids are
suspected, confirmation is sought by laparoscopy and hys-
teroscopy. The latter alone should be used to confirm and
treat intrauterine adhesions. If endometrial polyps, submucous
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Figure 17. Secondary amenorrhoea/anovulatory cycles-hirsutism, no Cushing's syndrome. DHEA-S = dehydroepiandrosterone sulphate;
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Figure 18. Abnormal uterine bleeding. FC = flow chart.
fibroids, or endometrial hyperplasia are suspected, con-
firmation and treatment should be done by hysteroscopy
and endometrial biopsy (Figure 20) (Rowe and Farley,
1988; Mishell etal, 1991; Sciarra, 1992).
Assessment of cervical factor
Evaluation of the cervical mucus and the postcoital test are
essential to assess the cervical factor. Providing that the
partner's semen parameters are normal, and vaginal inter-
course resulted in complete intravaginal ejaculation, the
interpretation of the results should be as described in
Figure 21. Persistently abnormal cervical mucus tested at
the right time is either due to the presence of congenital
cervical anomalies (e.g. lack of endocervical glands, ab-
sence of hormonal receptors) or due to destruction of the
endocervical mucosa by previous cervical surgery.
Normal cervical mucus and persistently poor results of
the postcoital test require cervical mucus culture to exclude
cervicitis and measurement of endocervical pH to exclude
hyperacidity. A sperm-cervical mucus contact (SCMC)
test is also needed to evaluate a poor postcoital test An
abnormal SCMC test indicates the presence of anti-sperm
antibodies (Figure 21) (Campana et al, 1987).
Diagnosis of male infertility
History-taking
We have classified the history into several well-identified
items, to assist in understanding possible cause—effect
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relationships. For simplicity and for the purpose of quick
revision of historical factors, one should refer to Figures 22
and 23.
General information
Age and other background information considered to be
relevant to male fertility, such as occupation, ethnic group,
religion etc., should be recorded.
Fertility history
Determining whether infertility is primary or secondary is
the first step in the fertility history. This is accomplished by
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asking the patient about previous marriages and outcomes.
Primary male infertility is the case when the man has never
impregnated a woman. Secondary male infertility applies
when the man has at some time impregnated a woman,
even if the woman is the partner in the presenting couple. In
the case of secondary infertility, one should determine the
time elapsed since impregnation. Whether a case of pri-
mary or secondary infertility, one should estimate the dur-
ation of infertility of the present couple. Inquiring about
previous work-ups and/or treatment for infertility is im-
portant and should be discussed in detail.
Family history
The patient should be asked about the existence of a family
history of infertility, spontaneous abortion, stillbirth and
congenital disease. Exposure to diethylstilbestrol in utero
may be a cause of male infertility (Speroff et al, 1989).
General history
Diseases can influence fertility either directly or indirectly.
Diabetes mellitus affects fertility through vascular, neuro-
logical and metabolic alteration. Tuberculosis may destroy
the urogenital tract Fever exceeding 38°C can affect sper-
matogenesis for the subsequent 6 months. Hypogonadism,
gynaecomastia and testicular atrophy are commonly ob-
served in men with hepatic cirrhosis (Yen and Jaffe, 1991).
Chronic renal failure is associated with hypogonadism and
hyperprolactinaemia (Yen and Jaffe, 1991). Spermato-
genic arrest has been observed in adrenogenital syndrome
(Martin-du Pan and Campana, 1993). Cystic fibrosis is a
known factor in male infertility. Bronchiectasis may be a
part of the immotile cilia syndrome or Young's syndrome.
Neurological diseases such as paraplegia, spina bifida,
neuropathies and congenital abnormalities of autonomic
innervation may affect sexual activity. Irradiation of the
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FLOW CHART 21. ASSESSMENT OF CERVICAL FACTOR
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Figure 21. Assessment of cervical factor. SCMC test = sperm-cervical mucus contact test
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Figure 22. History of the male partner. STD = sexually transmitted disease.
genital area is a risk factor and is dose-dependent perma-
nent sterility is observed for a single dose field with 600 to
800 rads (Martin-du Pan and Campana, 1993). Imetidine,
spironolactone, nitrofurantoin, sulphasalazine and cyto-
toxic drugs depress sperm density and quality (Speroff et
al, 1989). Tranquillizers, depressant drugs and some anti-
hypertensive drugs may cause impotence (Labby, 1982).
Urogenital history
Age at puberty (normal, precocious or delayed) should be
registered. Any pathology that could possibly cause tes-
ticular damage should be inquired about, including details
concerning the site, the treatment given, complications due
to treatment and evolution of the pathology. A history of
cryptorchidism may lead to testicular atrophy. Testicular
injury may initiate anti-sperm antibody formation or tes-
ticular damage, especially if it is accompanied by scrotal
bleeding or haematuria. Testicular torsion leads to testicu-
lar damage if not treated within 6 h. Mumps orchitis may be
the cause of testicular atrophy. Varicocele can impair tes-
ticular function (Yen and Jaffe, 1991).
History of sexually transmitted diseases
A positive history of sexually transmitted diseases is
suggestive of damage to and/or obstruction of the genital
tract. Data should be collected about the number of
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FLOW CHART 13. HISTORY OF THE MALE PARTKER-IATROCEN1C FACTORS,
OCCUPATIONAL AND ENVIRONMENTAL EXPOSURES
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Figure 23. History of the male partner — iatrogenic factors, occupational and environmental exposures.
episodes, the length of time passed since the most recent
episode, and treatment during the most recent episode. One
should also inquire about the causative organism.
Surgical history related to infertility
Testicular and scrotal operations, e.g. orchiectomy, orchio-
pexy, testicular detorsion, repair of inguinal hernias, vari-
cocelectomy and hydrocelectomy may be followed by
decreased fertility. Surgery on the epididymis and vasa
deferentia such as epididymovasostomy and vasovasos-
tomy may lead to anti-sperm antibody formation or genital
tract obstruction. Prostatectomy is followed by variable
degrees of impotence and retrograde ejaculation. Urinary
cystectomy, bladder neck operations, repair of urethral
strictures and repair of a hypospadias can all affect fertility.
Habits
The subject should be questioned about environmental and/
or occupational exposure to hazardous factors, such as radi-
ation, chemicals, drugs, heat and traumas. Some personal
habits can seriously affect men's fertility, such as wearing
tight pants, taking excessively hot baths and saunas (Martin-
du Pan and Campana, 1993). Cigarette smoking alters sperm
motility and count (Kulikauskas et al, 1985). Alcohol con-
sumption depresses sperm motility and count and, if used in
high concentration, leads to impotence (Labby, 1982).
Sexual history
Daily or more frequent intercourse may depress the sperm
count below normal levels. Abstinence for >7 days may
decrease motility due to increased proportions of older
spermatozoa (Speroff et al., 1989). For most couples, co-
itus every 36 h around the time of ovulation will give the
optimal chance for pregnancy. Intercourse is considered
adequate if it occurs more than twice per month. It is con-
sidered inadequate if the frequency is twice or less per
month, and may be an aetiological factor of infertility and a
possible sign of sexual dysfunction (Speroff et al, 1989).
Absence of libido or decreased libido is not only a cause
of decreased coital frequency, but may also be a sign of an
endocrine or a psychological disease. Dyspareunia may
underlie either an organic or a psychological problem.
Impotence is defined as the inability to achieve or sustain an
erection for a sufficient duration to have coitus and achieve an
orgasm (Yen and Jaffe, 1991). If coital erection is inadequate,
inquiry about early morning erection and masturbatory erec-
tion should be made. If both occur normally, the diagnosis of
primary impotence is excluded and coital impotence is at-
tributed in most cases to a psychological factor. In primary
impotence, erection cannot be achieved in any circumstance.
It may be due to hypogonadism with androgen failure, pelvic
vascular disease, or due to a systemic disease, such as diabetic
neuropathy, anaemia, tuberculosis and cancers (Labby, 1982).
Secondary impotence is due to psychological factors in 90%
of cases, and is characterized by failure of erection in the case
of coitus only. Sometimes the man is impotent only when he
consumes alcohol or uses some antihypertensive drugs or
central nervous system (CNS) depressants (Labby, 1982).
Ejaculation is considered adequate if it occurs intravagi-
nally with emission of semen from the external urethral
meatus. It is considered inadequate in the following condi-
tions: (i) extravaginal ejaculation that may be due to eja-
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FLOW CHART 24. PHYSICAL EXAMINATION O F T H E MALE PARTNER
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Figure 24. Physical examination of the male partner.
culation praecox or extreme hypospadias, (ii) retrograde
ejaculation into the bladder and (iii) anejaculation, i.e. fail-
ure of emission that may be of organic or psychological
origin (Rowe et aL, 1993). In the last case, if nocturnal
and/or masturbatory ejaculation occurs normally, this indi-
cates a psychological factor. Previous experience of painful
ejaculation may also be a factor behind anejaculation.
Physical examination
General examination
Height, arm span, and the upper to lower body ratio should
be measured to exclude eunuchoidism. Gait should be
looked at, as it may indicate the presence of a neurological
disease. Measurement of body weight and blood pressure
and a general physical examination will help to assess gen-
eral health, and will disclose any chronic debilitating disease.
If there is a history of neuropathy, endocrinopathy, cardio-
vascular, respiratory, renal or hepatic disease, or a clinical
suspicion is aroused during the physical examination, the
suspected disorder should be investigated thoroughly. Sec-
ondary sexual characteristics, including hair distribution,
body configuration, pubertal stage and evidence of gynaeco-
mastia should be looked for carefully (Figure 24).
Urogenital examination
The penis should be examined for size, circumcision, the
presence of surgical or traumatic scars, and induration
plaques of Peyronie's disease that may cause deformation of
the erect penis, thus hindering vaginal intercourse. If hypo-
spadias is present, one should look for whether the urethral
meatus is near the corona of the glans, or on the proximal part
of the penile shaft. Delivery of semen could still occur intra-
vaginally if the opening is in the distal part of the shaft
Semen will be delivered outside the vagina if the opening is
proximal or lies in the perineal region. Any discharge from
the urethra should be cultured. Non-tender induration of the
urethra suggests a stricture. Tenderness and induration may
indicate periurethritis (Hammond, 1987).
Each scrotum should be examined individually for the
presence of the testis, its size, the presence of a hydrocele,
masses, nodules and tenderness. The average size of the
adult testis is 5 X 3 cm, equivalent to a volume of 25 ml. The
lower size limit for a mature testis is about 4 x 2.5 cm,
corresponding to a volume of -15 ml. Smaller than normal
or very soft testes in an adult indicate impaired germinal
tissue mass, due either to primary testicular failure or to
hypothalamic-pituitary insufficiency. When determining the
size of the testis, the patient should be examined in the re-
cumbent position to avoid the risk of syncope. The scrotal
skin is stretched over the testicle, the contours of which are
isolated from the epididymis. The testis is palpated between
the thumb and first two fingers. The volume of each testicle
is compared with the corresponding ovoid of the Prader
orchiometer (Hammond, 1987; Rowe et aL, 1993).
A varicocele can only be detected with the patient stand-
ing; if present it should be graded according to the following
criteria; grade IE if the distended venous plexus visibly
bulges through the scrotal skin, grade II if there is intrascrotal
venous distension which is easily palpable but not visible,
and grade I when distension is only palpable while the pa-
tient is performing a Valsalva manoeuvre. Subclinical vari-
cocele should be recorded if no distension can be detected
but there is any abnormal finding during scrotal thermo-
graphy and/or Doppler echography (Rowe et aL, 1993).
The epididymis should be examined while the patient is
standing. The epididymis is examined between the thumb
and forefinger along its entire course. A normal one is
difficult to palpate; however, if the epididymis is palpable it
should have a regular outline, a soft consistency, and
should not be tender. Nodular induration may suggest tu-
berculosis. Any swelling and tenderness may indicate
epididymitis (Hammond, 1987; Rowe etai, 1993).
The vas deferens should be palpated along its entire
course below the inguinal canal. A normal one should be
palpable, but not thickened (Hammond, 1987; Rowe etai,
1993). Inguinal examination can be performed while the
patient is standing, or in a recumbent position. Any pal-
pable or visible abnormalities should be recorded in detail.
If the testes are not palpable in the scrotum, an attempt to
palpate them in the inguinal region should be made (Ham-
mond, 1987; Rowe etai., 1993).
Rectal examination is carried out with the patient in the
knee-elbow position. Palpation should be performed from
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the crania] to the caudal part and from lateral to medial. The
prostate is normally soft, regular and not tender upon slight
pressure. The central groove should be easily identified in a
normal prostate. The seminal vesicles are not palpable if
normal (Hammond, 1987; Rowe etal, 1993).
After completion of the history and physical examination,
some patients can be diagnosed directly as having sexual
and/or ejaculatory dysfunction. Sexual dysfunction applies
to those patients with inadequate erection and/or inadequate
frequency of intercourse. Ejaculatory dysfunction applies
when there is normal intercourse, but followed either by
anejaculation or ejaculation occurring outside the vagina.
Retrograde ejaculation should be suspected in patients with
normal intercourse and orgasm, but no emission of semen.
To be sure of the diagnosis, a post-orgasm urine sample
should be analysed for the presence of spermatozoa.
In the case of patients who are not diagnosed as having
sexual or ejaculatory dysfunction, one should advance to
the next step in the laboratory protocol (Figure 24).
Laboratory methods for the diagnosis of male
infertility
Laboratory methods available for diagnosing male infertil-
ity include semen analysis and examination of the interac-
tions between spermatozoa and cervical mucus. Here, we
review the various parameters that can be analysed and
discuss their interpretation and significance. The reader
should refer to original sources for detailed description of
technical procedures.
Semen analysis
Definitions concerning semen variables are given in Table
I (World Health Organization, 1992).
Normal values: Semen analysis comprises a set of de-
scriptive measurements of spermatozoa and seminal fluid
parameters that help to estimate semen quality. Normal va-
lues of semen parameters issued by the World Health Organ-
ization (WHO) in 1992 are generally used as reference
values (Table II). Ideally, each laboratory should set its own
normal values reflecting the specific population analysed,
but this is limited on practical grounds by the availability of
Table I. Nomenclature for semen variables
semen from men of proven fertility who have recently
achieved impregnation. It should be emphasized that semen
is an exception among biological fluids as its parameters
display very wide intra- and inter-individual variations.
Therefore, semen analysis should be repeated to take into
account intra-individual variations over time in order to con-
firm abnormal parameters. Sperm parameters assessed in
semen analysis include the number of sperm cells, and the
viability, motility and morphology of the sperm population.
Ejaculate volume, sperm concentration, total sperm count
and viability: The major component of the ejaculate volume
is made up of secretions from the accessory glands (seminal
vesicles and prostate). Consequently, the ejaculate volume is
not directly related to spermatogenesis, and the sperm con-
centration (number of spermatozoa/ml) varies according to
the ejaculate volume. The total number of spermatozoa per
ejaculate reflects spermatogenesis and is related to the dur-
ation of sexual abstinence before collection. As the ejaculate
volume is related to the secretory function of the seminal
vesicles and prostate, decreased ejaculate volume reflects
impaired accessory gland function. Vital staining of the sper-
matozoa allows quantitation of the fraction of living cells
independently of their motility.
Sperm motility: Sperm motility can be assessed either by
manual counting or by using a computer-assisted semen
analysis (CASA) system. Motility is assessed at the time of
semen liquefaction and after 1 and 3 h to detect asthenozoo-
spermia Manual counting classifies sperm cells into several
categories (immotile, locally motile, non-linear and linear mo-
tile), relying on qualitative subjective criteria of selection.
Many infertility centres now use CASA systems for objective
measurement of sperm motion, and positive correlations have
been found between motion parameters, such as the amplitude
of lateral head displacement, curvilinear velocity, linearity and
straight-line velocity, and fertilization rates in vitro (Barlow et
al., 1991; Liu et al^ 1991). The threshold levels for these
motion characteristics have still to be determined, before they
can be used clinically in a prospective way (Oehninger et al.,
1992). Moreover, data obtained by different groups are often
difficult to compare due to the lack of consensus about para-
meter setting, as well as technical differences between differ-
ent systems (Davis and Boyers, 1992).
Classification Definition
Normospermla
ODgozoospermia
Asthenozoospermia
Teratozoospermia
Oligoasthenoteratozoospermia
Azoospermia
Aspermia
normal ejaculate as defined in flow chart 28
sperm concentration <2Q x 10fyml
<50% spermatozoa with forward progression or <25% spermatozoa wtth rapid linear progression
<30% spermatozoa with normal morphology
signifies disturbances of aD three variables (combination of only two prefixes may also be used)
no spermatozoa in the ejaculate
no ejaculate
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Table II. Normal values of semen variables (from WHO, 1992)
Volume
pH
Sperm concentration
Total sperm count
Motility
(within 60 min of ejaculation)
Morphology
Vitality
White blood cells
a-Glucosidase (neutral)
Zinc
Citric acid
Acid phosphatase
Fructose
Immunobead test
Mixed antiglobulin reaction
test
£2.0 ml
7.2-8.0
£20x106/ml
2:40 X106
£50% with forward motility or
£25% with rapid progression
£30% with normal forms
£75% alive
<1 x lOfyml
£20 mU/ejaculate
£2.4 (imol/ejaculate
£52 nmol/ejaculate
£200 U/ejaculate
£i3fimol/ejaculate
<20% spermatozoa with adherent
particles
<10% spermatozoa with adherent
particles
Sperm morphology: The evaluation of sperm morphol-
ogy is performed after Papanicolaou or similar staining and
consists of detailed examination of 100 sperm cells as well
as other cells present in the ejaculate, including immature
sperm cells and leukocytes. Sperm cells represent a unique
population in which up to 50% of the cells can have mor-
phological defects in normal fertile individuals. These de-
fects affect the head, midpiece, or the tail of the sperm cell.
The percentage of spermatozoa with normal morphology is
recorded, as well as individual abnormalities, to detect pre-
dominant abnormalities that suggest genetic defects affec-
ting spermatogenesis. The rare cases of monomorphic
teratozoospermia as well as severe asthenozoospermia can
be subjected to electron microscopic analysis to detect
specific defects at the ultrastructural level, particularly in
the flagella, where abnormal microtubule assembly can be
found in such conditions as the immotile cilia syndrome
(see Zamboni, 1992, for review). Recently, Kruger and
colleagues reported that the use of stricter morphology
criteria than those recommended by WHO gave better pre-
dictive value in in-vitro fertilization (TVF). They report
normal FVF rates for cases with >14% normal sperm mor-
phology (Kruger et al., 1988; Menkveld et al., 1990).
There is still controversy about these data, and their signifi-
cance in in-vivo fertilization is unknown (Check, 1992).
The evaluation of sperm morphology also includes
identification of other cell types present in semen, such as
immature sperm cells and leukocytes. The presence of im-
mature germ cells in semen indicates spermatogenic dys-
function at the testicular level, whereas the presence of
leukocytes in concentrations >1 X lO^ml indicates inflam-
matory conditions possibly related to infection. Direct
measurement of infectious contamination is obtained from
bacteriological cultures of both aerobic and anaerobic
microorganisms. In normal conditions, semen is not sterile
but rather colonized at low levels by a variety of microor-
ganisms. Recent studies have shown that bacterial coloniz-
ation does not have a negative impact on sperm-cervical
mucus interaction (Chandra and Gray, 1991; Eggert-Kruse
et al., 1992). Distinction between immature germ cells and
leukocytes can be difficult, and specific staining of leuko-
cytes, such as peroxidase staining or anti-leukocyte mono-
clonal antibodies, can be used to clarify the origin of round
cells in semen (FIsch and Lipshultz, 1992).
Anti-sperm antibodies: The presence of anti-sperm anti-
bodies in semen can alter the fertilizing ability of spermato-
zoa. Being haploid, sperm cells display different surface
antigens from their diploid counterparts and are immuno-
genic. Under normal circumstances, they are protected
from the man's immune system by a basal membrane con-
stituting the blood-testis barrier. When this barrier is rup-
tured, sperm cells induce the synthesis of anti-sperm
antibodies. Antibodies adsorbed on the sperm surface can
be detected by immunological assays using secondary
immunoglobulin (Ig) class-directed antibodies coupled to
beads. The percentage of spermatozoa adhering to the
beads reflects in a semi-quantitative manner the presence
of anti-sperm antibodies. Currently available tests can de-
tect IgG and IgA in semen and in serum (Fisch and Lip-
shultz, 1992). However, there is a poor correlation between
the presence of anti-sperm antibodies in serum and semen,
and serum anti-sperm antibodies have been shown not to
influence fertility prognosis (Eggert-Kruse et al., 1989a).
Sperm-bound antibodies have been found to impair sperm
function only when the degree of antibody binding is very
high (>50%) (Barratt et al., 1992).
Accordingly, detection of anti-sperm antibodies in
semen should be preferred, and the presence of anti-sperm
antibodies, detected by the anti-IgG test, can now be con-
firmed by the recently commercialized anti-IgA assay.
Biochemical analysis: Biochemical analysis of secretory
components in semen from the prostate, the seminal ves-
icle and the epididymis gives information about the func-
tional state of these organs. Markers include fructose as a
seminal vesicle marker, zinc or acid phosphatase as pros-
tate markers and carnitine as an epididymis marker (von
der Kammer et al., 1992; Wetterauer, 1986). Huszar et al.
(1990, 1992) have reported that sperm creatine kinase, a
key metabolic enzyme, inversely correlates with fertilizing
potential and could be used as a biochemical marker of
sperm fertilizing capacity.
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Figure 25. Semen analysis. FC = flow chart.
If the results of semen analysis are repeatedly abnormal,
then other variables should be considered (Figure 25).
Sperm-cervical mucus interaction
Evaluation of sperm—cervical mucus interaction is based
on functional assays and includes the postcoital test, the
sperm-cervical mucus contact test and the in-vitro sperm-
cervical mucus penetration assay.
Postcoital test: The postcoital test entails analysis of the
cervical mucus a few hours after intercourse. It reflects the
physiological situation in vivo and assesses both the quality
of the cervical mucus and the penetration ability of sper-
matozoa. The quality of cervical mucus varies during the
cycle and is favourably influenced by oestrogens, becom-
ing more abundant and fluid at the time of ovulation.
Therefore, postcoital tests are scheduled just before ovula-
tion, as determined by cervical mucus changes or, more
accurately, by follicular sizing by ultrasonography. The
number of motile spermatozoa per high-power micro-
scopic field is recorded, and, according to WHO guide-
lines, the test is considered positive when >10 motile
spermatozoa are found per field. Cervical mucus evalu-
ation (including volume, consistency, feming, spinnbar-
keit, cellularity and pH) is important for the interpretation
of postcoital test results with respect to sperm function. A
decreased number of spermatozoa in the cervical mucus
when the cervical mucus score is low reflects inadequate
mucus rather than impaired sperm function. Cervical
mucus is colonized by spermatozoa that are stored for sev-
eral hours in cervical crypts. Sperm cells then gradually
migrate through the cervix. Consequently, sperm cells are
present in the cervical mucus constantly for at least 12 h
following intercourse, and the timing of the postcoital test
(6-12 h after intercourse) allows testing of the viability of
spermatozoa in this environment (Kremer and Jager, 1988).
Abnormal penetration of cervical mucus by spermatozoa has
been associated with the presence of immobilizing anti-
sperm antibodies (Kremer and Jager, 1992; Pretorius and
Franken, 1989). Repeatedly abnormal postcoital test results
with normal cervical mucus associated with normal sperm
concentration and moulity should be investigated by addi-
tional tests such as anti-sperm antibody detection in the
semen, the sperm-cervical mucus contact test, and the in-
vitro cervical mucus penetration assay.
The postcoital test has been used for several decades, but
is reported to be inaccurate and to lack a consensus regard-
ing normal values and methodology (Griffith and Grimes,
1990; Markham, 1991). Part of the problem may be due to
the heterogeneous nature of cervical mucus that prevents
quantitative determination of sperm concentration. The
postcoital test nevertheless remains an inexpensive and
non-invasive procedure that gives information about the
occurrence of ejaculation, and the ability of sperm cells to
function within the cervical environment (Markham,
1991). A new approach to the objective assessment of the
postcoital test has been recendy described by Campana et
al (1991). The cervical mucus is examined after incuba-
tion with bromelains. This procedure allows quantitative
measurement of the sperm count in the liquefied cervical
mucus in a Neubauer chamber.
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Sperm-cervical mucus contact test: The sperm-cervical
mucus contact test consists of mixing semen and cervical
mucus in vitro and measuring the appearance of immobilized
'shaking' motile spermatozoa. This is interpreted as the ad-
herence of antibody-coated sperm cells to cervical mucus
(Kremer and Jager, 1988) and has been shown to correlate
with semen concentration of anti-sperm antibodies and preg-
nancy rates (Franken et al., 1988). This test can be performed
in parallel with donor semen or donor cervical mucus, and
therefore makes it possible to discriminate between a male
and a female origin of the sperm immobilizing factor.
In-vitro cervical mucus penetration test: The third test of
sperm-cervical mucus interactions involves the penetra-
tion of cervical mucus by spermatozoa in vitro. The mucus
is placed in a capillary tube, one end of the tube is dipped in
semen and the penetration and motility of spermatozoa in
the mucus column are measured. It can be performed with
homologous or donor cervical mucus (Kremer and Jager,
1988). Using cervical mucus standardized by oestrogen
treatment, this test has been shown to have good predictive
value of fertility (Eggert-Kruse etal., 1989b). Alternative-
ly, this test can be performed with commercial mid-cycle
bovine cervical mucus or hyaluronic acid gels. The use of
alternative material to human cervical mucus has practical
advantages (availability, reproducibility), but may be less
informative than with human material. A better correlation
of fertility and sperm penetration was reported for stan-
dardized human than for bovine cervical mucus, and sperm
motility was found to decline more .rapidly in the latter
(Eggert-Kruse et al, 1989b). Moreover, the distance of
sperm penetration into bovine cervical mucus was found to
correlate with IVF, but was not accurate enough for predic-
tion (Morrow et al., 1992). Sperm penetration into hyaluro-
nate polymers seems to yield better correlations with
motility, and with sperm fusion with hamster oocytes, than
bovine cervical mucus (Aitken et al, 1992), but direct
correlation with fertility has not yet been shown. Conse-
quently, whenever possible, human cervical mucus should
be used and, for specific male factor detection, oestrogen
standardized donor mucus should be preferred.
Sperm functional assays
Sperm functional assays have been developed in an attempt
to find a good predictive test of male fertility. We discuss
here the hemizona assay, the hamster egg penetration assay
and the sperm hypo-osmotic swelling assay.
Hemizpna assay: The hemizona assay is the most recent-
ly developed sperm functional assay. It measures the bind-
ing of capacitated spermatozoa to isolated human zona
pellucida. Human oocytes are bisected by micromanipula-
tion, thus allowing for an internally controlled comparison
of sperm binding to matching hemizonae surfaces in the
patient relative to a fertile control (Burkman et al., 1988).
The two matched hemizonae of the human oocytes have
the advantage of providing functionally equal surfaces,
allowing a controlled comparison of sperm binding, and
therefore limiting the amounts of oocytes used. Ethically
this assay is acceptable, as the microsurgical bisection of
the oocyte prevents any inadvertent fertilization. The
hemizona assay has been found to be predictive of IVF
outcome, with positive and negative predictive values of 83
and 95% respectively (Oehninger et al., 1989). The major
problem with this assay is the limited availability of human
oocytes. Eventually, it could be replaced by a standardized
kit in which recombinant human zona sperm receptors
mimic the natural functional hemizonae used now.
Sperm penetration into zjona-free hamster oocytes: The
zona-free hamster oocyte sperm penetration assay is a het-
erologous bioassay, originally developed to test capacitation,
acrosome reaction, fusion and sperm chromatin decondensa-
tion (Campana et al, 1983). Cross-species fertilization is
made possible by removing the zona pellucida of hamster
oocytes. Using the original test conditions, the limiting step
is the low incidence of spontaneous acrosome reactions in
human sperm populations incubated in vitro, and therefore it
has been described as measuring the ability of spermatozoa
to undergo the acrosome reaction, rather than the overall
fertilization process (Tesarik and Testart, 1989). Optimized
procedures have been introduced recently that decrease the
number of false positives, making it more specific and giving
good predictive value of IVF (Fisch and Lipshultz, 1992).
Hypo-osmotic swelling of sperm flagella: The hypo-
osmotic swelling (HOS) test measures sperm membrane
integrity by examining its ability to swell when exposed to
hypo-osmotic media, and has been claimed to be relevant
to fertilizing ability. The biological significance of this test
is unclear and its validity is still controversial. Some
authors have described subnormal HOS test scores in pa-
tients with low IVF rates but normal semen analysis
(Check et al., 1992), whereas other authors have found that
the HOS test is equivalent to viability staining and corre-
lates with semen analysis data but not with the hamster
oocyte penetration test; they conclude that the HOS test
does not add relevant information to that obtained from
semen analysis about the fertilizing potential of semen
(Van den Saffele et al., 1992).
Further Investigation
Azoospermia and other sperm abnormalities
In all azoospermic patients (Figure 26), serum follicle
stimulating hormone (FSH) should be determined. For
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Figure 26. Azoospermia.
patients with elevated FSH concentrations, karyotyping is
indicated. If the FSH concentrations are normal, it is
necessary to measure luteinizing hormone (LH) and testos-
terone for differential diagnosis. High serum concentra-
tions of LH and testosterone are diagnostic of androgen
resistance. If both LH and testosterone serum concentra-
tions are normal, the diagnosis is either obstructive azoo-
spermia or testicular failure, depending on history and the
results of scrota] exploration, vasography and testicular
biopsy. Azoospermic patients with hypogonadotrophic hy-
pogonadism are candidates for gonadotrophin-releasing
hormone testing, measurement of serum prolactin, and X-
ray evaluation of the sella turcica to differentiate between a
hypothalamic or pituitary origin. Oligozoospermic patients
(Figure 27) may need post-orgasm urine analysis to ex-
clude partial retrograde ejaculation. Apart from that, the
condition may be due to partial genital tract obstruction,
testicular failure, or varicoceles, or it may be idiopathic.
Severe asthenozoospermic patients require electron micro-
scopic study of their spermatozoa to isolate structural
anomalies of the tail. An immunological work-up to ex-
clude autoimmunization and/or seminal fluid culture to
exclude genital tract infection may be required (Figure 27).
In cases of teratozoospermia, one should start first by ex-
cluding the presence of monomorphic genetic syndromes
such as globozoospermia, microcephaly and short-tail
spermatozoa. The diagnosis then depends on the type of
abnormal morphology. In the presence of abnormal heads,
testicular failure of whatever aetiology should be suspected.
Abnormal tails require assessment of the male accessory sex
glands for the presence of infection (Figure 27).
Infection
Male accessory gland infection is diagnosed if the patient
has abnormal spermatozoa and fulfills at least two of the
following criteria: (i) history and physical signs: a history
of urinary tract infection, epididymitis, sexually trans-
mitted disease, or during the physical examination there is
a thickened or tender epididymis, thickened vas deferens,
and/or abnormal rectal examination; (ii) abnormal pros-
tatic expression fluid and/or abnormal urine after prostatic
massage; (iii) ejaculate signs: >1 x 106 white blood cells
(WBQ/ml in the ejaculate, culture with significant growth
of pathogenic bacteria, abnormal appearance and/or vis-
cosity and/or pH and/or abnormal biochemistry of the
seminal plasma
To diagnose infection, a combination of two items from
any of these categories, or two factors from catergory (iii)
should be present To obtain prostatic expression fluid, a
prostatic massage via the rectum should be performed. The
fluid expressed from the external urethral meatus is col-
lected on a glass slide and is either examined wet in phase
contrast or smeared and stained with Giemsa Normal pros-
tatic expression fluid contains <5 WBC/high-power field
(HPF). In abnormal fluid, >10 WBC/HPF are present, typi-
cally in mucus streaks and together with degenerated pros-
tatic cells. The presence of 5-10 WBC/HPF without mucus
streaks is of doubtful significance. If no prostatic expression
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Figure 27. Oligo- and/or astheno- and/or teratozoospermia. FC = flow chart; MAR = mixed antiglobulin reaction.
fluid is obtained after prostatic massage, the patient is
asked to void urine and the first void of -10 ml of urine is
used for bacteriological and cytological analysis. The pres-
ence of >5 white or red blood cells in the urinary sediment
is considered abnormal (Rowe et ai, 1993).
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